WO2002016360A3 - Nitrogenous heterocyclic compounds - Google Patents
Nitrogenous heterocyclic compounds Download PDFInfo
- Publication number
- WO2002016360A3 WO2002016360A3 PCT/US2001/041749 US0141749W WO0216360A3 WO 2002016360 A3 WO2002016360 A3 WO 2002016360A3 US 0141749 W US0141749 W US 0141749W WO 0216360 A3 WO0216360 A3 WO 0216360A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- kinases
- heterocyclic compounds
- phosphorylation
- pharmaceutically acceptable
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/344,907 US20040259881A1 (en) | 2001-02-02 | 2001-08-17 | Nitrogenous heterocyclic compounds |
AU2001293207A AU2001293207A1 (en) | 2000-08-18 | 2001-08-17 | Nitrogenous heterocyclic compounds |
EP01973652A EP1309567A2 (en) | 2000-08-18 | 2001-08-17 | Nitrogenous heterocyclic compounds |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26612000P | 2000-08-18 | 2000-08-18 | |
US60/266,120 | 2000-08-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002016360A2 WO2002016360A2 (en) | 2002-02-28 |
WO2002016360A3 true WO2002016360A3 (en) | 2002-06-13 |
Family
ID=23013247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/041749 WO2002016360A2 (en) | 2000-08-18 | 2001-08-17 | Nitrogenous heterocyclic compounds |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1309567A2 (en) |
AU (1) | AU2001293207A1 (en) |
WO (1) | WO2002016360A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1315715B1 (en) | 2000-08-18 | 2008-07-23 | Millennium Pharmaceuticals, Inc. | Quinazoline derivatives as kinase inhibitors |
EP1309568B1 (en) | 2000-08-18 | 2011-02-16 | Millennium Pharmaceuticals, Inc. | [(quinazolin-4-yl)piperazin-4-yl]thiocarboxamide compounds as inhibitors of the phosphorylation of a PDGF receptor |
AU2001293209A1 (en) | 2000-08-18 | 2002-03-04 | Cor Therapeutics, Inc. | Nitrogenous heterocyclic compounds |
EP1330444B1 (en) | 2000-11-01 | 2011-03-23 | Millennium Pharmaceuticals, Inc. | Nitrogenous heterocyclic compounds and process for making them |
US6960580B2 (en) | 2001-03-08 | 2005-11-01 | Millennium Pharmaceuticals, Inc. | Nitrogenous heterocyclic substituted quinoline compounds |
CN100540539C (en) * | 2003-07-30 | 2009-09-16 | 宇部兴产株式会社 | Preparation 6, the method for 7-two (2-methoxy ethoxy) quinazoline-4-one |
US8071768B2 (en) | 2005-06-10 | 2011-12-06 | Janssen Pharmaceutica, N.V. | Alkylquinoline and alkylquinazoline kinase modulators |
US7825244B2 (en) | 2005-06-10 | 2010-11-02 | Janssen Pharmaceutica Nv | Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis |
AU2013211455B2 (en) * | 2005-09-19 | 2017-12-07 | Neuronascent, Inc. | Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration |
EP1937252B1 (en) * | 2005-09-19 | 2017-10-25 | Neuronascent, Inc. | Compositions for stimulating neurogenesis and inhibiting neuronal degeneration |
CN108358798A (en) * | 2018-02-12 | 2018-08-03 | 黑龙江鑫创生物科技开发有限公司 | A kind of method of micro passage reaction synthesis Tarceva intermediate |
CN112300082B (en) * | 2019-07-26 | 2022-04-26 | 暨南大学 | Phenyl piperazine quinazoline compound or pharmaceutically acceptable salt thereof, preparation method and application |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0882717A1 (en) * | 1996-10-01 | 1998-12-09 | Kyowa Hakko Kogyo Kabushiki Kaisha | Nitrogenous heterocyclic compounds |
-
2001
- 2001-08-17 WO PCT/US2001/041749 patent/WO2002016360A2/en not_active Application Discontinuation
- 2001-08-17 AU AU2001293207A patent/AU2001293207A1/en not_active Abandoned
- 2001-08-17 EP EP01973652A patent/EP1309567A2/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0882717A1 (en) * | 1996-10-01 | 1998-12-09 | Kyowa Hakko Kogyo Kabushiki Kaisha | Nitrogenous heterocyclic compounds |
Also Published As
Publication number | Publication date |
---|---|
WO2002016360A2 (en) | 2002-02-28 |
AU2001293207A1 (en) | 2002-03-04 |
EP1309567A2 (en) | 2003-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1964839A3 (en) | Quinazoline derivatives as kinase inhibitors | |
WO2002072578A3 (en) | (homo) piperazine substituted quinolines for inhibiting the phosphorylation of kinases | |
WO2002016360A3 (en) | Nitrogenous heterocyclic compounds | |
WO2005047244A3 (en) | Inhibition of fgfr3 and treatment of multiple myeloma | |
WO2002016362A3 (en) | Nitrogenous heterocyclic compounds | |
WO2000043373A3 (en) | Kinase inhibitors | |
WO2008005956A3 (en) | Pyrrolotriazine kinase inhibitors | |
WO2001019829A3 (en) | Pyrazolopyrimidines as therapeutic agents | |
CA2400447A1 (en) | Kinase inhibitors | |
WO2004054514A3 (en) | C-6 modified indazolylpyrrolotriazines | |
HK1016174A1 (en) | Nitrogenous heterocyclic compounds | |
MY134848A (en) | Pyrrolo[2,1-f] [1,2,4] triazine inhibitors of kinases | |
WO2004001059A3 (en) | Heterocyclic inhibitors of kinases | |
WO2005037836A3 (en) | Imidazo ‘1, 5 - a ! pyrazine tyrosine kinase inhibitors | |
WO2003042172A3 (en) | C-5 modified indazolylpyrrolotriazines | |
WO2000055159A3 (en) | Substituted aza-oxindole derivatives | |
WO2004018419A3 (en) | Benzimidazole quinolinones and uses thereof | |
TR199801530T2 (en) | Quinazoline derivatives as VEGF inhibitors. | |
MY145634A (en) | Pyrrolotriazine compounds as kinase inhibitors | |
WO2002016361A3 (en) | Nitrogenous heterocyclic compounds | |
WO2001012579A3 (en) | New stilbenes with vascular damaging activity | |
DE60144284D1 (en) | NITROGENIC HETEROCYCLIC COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF | |
NO20055518L (en) | 5-hydroxyindoles with N-oxide groups, use thereof as phosphodiesterase 4 inhibitor | |
WO2002094768A3 (en) | Aza hydroxylated ethyl amine compounds | |
WO2002055541A3 (en) | Peptides having inhibiting activity on the production of nitric oxide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001973652 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001973652 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10344907 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001973652 Country of ref document: EP |